文献速递免疫规划传染病防控与疫情报告

东部和南部非洲国家轮状病毒疫苗引入前后的轮状病毒株多样性

Rotavirus strain diversity in Eastern and Southern African countries before and after vaccine introduction.
PubMed 文献 · Vaccine · 2017-12-02

该研究基于世界卫生组织轮状病毒监测网络,报告了2010至2015年15个东部和南部非洲国家5岁以下急性胃肠炎患儿中轮状病毒株的分布,并在6个国家探讨疫苗引入后是否出现非疫苗株或异常株。结果显示G1P[8]占23.8%,疫苗引入前后流行株无差异,非典型G/P组合低频检出(2%)。

要点

  • 2010至2015年15个东部和南部非洲国家监测中,G1P[8]占23.8%,其次为G2P[4](11.8%)、G9P[8](10.4%)。
  • 轮状病毒疫苗引入前后 circulating 株无差异,仅见随时间出现的年度波动。
  • 非典型G/P组合(如G1P[4]、G2P[8]、G9P[4]、G12P[4])以低频率(2%)检出。

核心结论

  • 疫苗引入后菌株替换备受关注,但在6个东部和南部非洲国家早期阶段尚不清楚观察到的轮状病毒株周期性变化是否由疫苗压力所致,抑或仅为自然年度波动的一部分,需要长期监测。

研究设计与样本

  • 研究为2010至2015年世界卫生组织轮状病毒主动监测的一部分,在15个东部和南部非洲国家的哨点医院采集5岁以下急性胃肠炎患儿粪便样本,并在疫苗引入前后进行检测。
  • 样本由国家及哨点实验室用酶免疫法检测A组轮状病毒,在南非的世界卫生组织轮状病毒区域参考实验室进行分子特征分析:PAGE(n=4186)、G和P基因分型(n=6447)及G和P型DNA测序(n=400)。

主要发现

  • 六年监测期内,15个东部和南部非洲国家中23.8%的毒株为G1P[8],其次为G2P[4](11.8%)、G9P[8](10.4%)、G12P[8](4.9%)、G2P[6](4.2%)和G3P[6](3.7%)。
  • 轮状病毒疫苗引入前后循环毒株无差异,随时间观察到毒株的年度波动。
  • 可能通过基因群间或基因型间重配产生的非典型轮状病毒G和P组合(如G1P[4]、G2P[8]、G9P[4]和G12P[4])以低频率(2%)检出。
  • 系统发育分析显示非洲毒株遗传关系密切,毒株在同一谱系/亚谱系或单系分支中聚集形成非洲簇。

局限性

  • 在6个东部和南部非洲国家,早期阶段尚不清楚观察到的轮状病毒株周期性变化是否由疫苗压力所致,抑或仅为自然年度波动的一部分,需要长期监测。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The African Rotavirus Surveillance Network has been detecting and documenting rotavirus genotypes in the African sub-continent since 1998 in anticipation of the rollout of rotavirus vaccination in routine Expanded Programme on Immunisation. This paper reports distribution of the rotavirus strains circulating in 15 Eastern and Southern African (ESA) countries from 2010-2015 as part of active World Health Organization (WHO) rotavirus surveillance, and investigates possibility of emergence of non-vaccine or unusual strains in six selected countries post-vaccine introduction. MATERIAL AND METHODS: Stool samples were collected from children <5 years of age presenting with acute gastroenteritis at sentinel hospitals pre- and post-rotavirus vaccine introduction. Samples were tested for group A rotavirus using an enzyme immunoassay by the national and sentinel laboratories. At the WHO Rotavirus Regional Reference Laboratory in South Africa, molecular characterisation was determined by PAGE (n = 4186), G and P genotyping (n = 6447) and DNA sequencing for both G and P types (n = 400). RESULTS: The six-year surveillance period demonstrated that 23.8% of the strains were G1P[8], followed by G2P[4] (11.8%), G9P[8] (10.4%), G12P[8] (4.9%), G2P[6] (4.2%) and G3P[6] (3.7%) in 15 ESA countries. There was no difference in circulating strains pre- and post-rotavirus vaccine introduction with yearly fluctuation of strains observed over time. Atypical rotavirus G and P combinations (such as G1P[4], G2P[8], G9P[4] and G12P[4]) that might have arisen through inter-genogroup or inter-genotypes reassortment were detected at low frequency (2%). Close genetic relationship of African strains were reflected on the phylogenetic analysis, strains segregated together to form an African cluster in the same lineages/sub-lineage or monophyletic branch. CONCLUSION: There has been considerable concern about strain replacement post-vaccine introduction, it was not clear at this early stage whether observed cyclical changes of rotavirus strains were due to vaccine pressure or this was just part of natural annual fluctuations in the six ESA countries, long-term surveillance is required.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Seheri LM, Magagula NB, Peenze I, et al. Rotavirus strain diversity in Eastern and Southern African countries before and after vaccine introduction. Vaccine. 2017. PMID: 29203181. doi:10.1016/j.vaccine.2017.11.068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。